gadolinium dtpa has been researched along with 4-methoxyamphetamine in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (4-methoxyamphetamine) | Trials (4-methoxyamphetamine) | Recent Studies (post-2010) (4-methoxyamphetamine) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 20,407 | 245 | 6,335 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | 4-methoxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.173 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, CR; Chow, K; Friedrich, MG; Haykowsky, M; Isaac, D; Kim, D; Kumar, A; Paterson, I; Thompson, R; Toma, M | 1 |
1 other study(ies) available for gadolinium dtpa and 4-methoxyamphetamine
| Article | Year |
|---|---|
Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.
Topics: Adult; Aged; Contrast Media; Death; Female; Fibrosis; Follow-Up Studies; Gadolinium DTPA; Heart Transplantation; Hospitalization; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Postoperative Complications; Prognosis; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling | 2013 |